Is logP a convenient criterion to guide the choice of solvents for biphasic enzymatic reactions?

Angewandte Chemie - International Edition

Volumn 42, Issue 26, 2003, Pages 2993-2996

  Filho, Murillo Villela ^a   Stillger, Thomas ^a   Müller, Michael ^a   Liese, Andreas ^a   Wandrey, Christian ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Asymmetric catalysis; Biphasic catalysis; Lyases; Medium engineering; Oxidoreductases

Indexed keywords

CATALYSTS; ENZYMES; SOLVENTS;

ENANTIOSELECTIVITY;

REACTION KINETICS;

ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KETONE; LYASE; ORGANIC SOLVENT; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SOLVENT;

ARTICLE; CATALYSIS; CHEMICAL REACTION; ENANTIOMER; ENZYME ACTIVITY; ENZYME MECHANISM; HYDROPHOBICITY; REDUCTION; STEREOCHEMISTRY;

ACETOPHENONES; ALCOHOL DEHYDROGENASE; CATALYSIS; ENZYME STABILITY; HALF-LIFE; HEXANOIC ACIDS; HYDROPHOBICITY; ORGANIC CHEMICALS; SOLVENTS; WATER;

EID: 0042808596     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200351089     Document Type: Article

References (51)

1. a) C.-H. Wong, G. M. Whitesides, Enzymes in synthetic organic chemistry, Elsevier Science, New York, 1994;
2. b) K. Faber, Biotransformations in organic chemistry, Springer, Berlin, 1997;
3. c) M.-R. Kula, U. Kragl, in Stereoselective Biocatalysis (Ed.: R.N. Patel), Marcel Dekker, New York, 2000, pp. 839-866;
4. d) A. Liese, K. Seelbach, C. Wandrey, Industrial Biotransformations, Wiley-VCH, Weinheim, 2000.
5. a) E. Schmidt, H. U. Blaser, P. F. Fauquex, G. Sedelmeier, F. Spindler in Microbial reagents in organic synthesis (Ed.: S. Servi), Kluver Academic Publishers, Dordrecht, 1992, pp. 377-388;
6. b) B. Bachmann, D. Seebach, Helv. Chim. Acta 1998, 81, 2430-2461;
7. c) S. Rissom, J. Beliczey, G. Giffels, U. Kragl, C. Wandrey, Tetrahedron: Asymmetry 1999, 10, 923-928;
8. d) A. Hage, D. Petra, J. Field, D. Schipper, J. Wijnberg, P. Kamer, J. Reek, P. van Leeuwen, R. Wever, H. Schoemaker, Tetrahedron: Asymmetry 2001, 12, 1025-1034;
9. e) S. Laue, L. Greiner, J. Wöltinger, A. Liese, Adv. Synth. Catal. 2001, 343, 711-720.
10. W. Stampfer, B. Kosjek, C. Moitzi, W. Kroutil, K. Faber, Angew. Chem. 2002, 114, 1056-1059; Angew. Chem. Int. Ed. 2002, 41, 1014-1017.
11. W. Stampfer, B. Kosjek, C. Moitzi, W. Kroutil, K. Faber, Angew. Chem. 2002, 114, 1056-1059; Angew. Chem. Int. Ed. 2002, 41, 1014-1017.
12. a) A. Klibanov, Nature 2001, 409, 241-246;
13. b) A. Schmid, J. S. Dordick, B. Hauer, A. Kiener, M. Wubbolts, B. Witholt, Nature 2001, 409, 258-268;
14. c) A. Liese, T. Zelinski, M.-R. Kula, H. Kierkels, M. Karutz, U. Kragl, C. Wandrey, J. Mol. Catal. B 1998, 4, 91-99.
15. a) G. Carrea, Trends Biotechnol. 1984, 2, 102-106;
16. b) N. Kizaki, Y. Yasohara, J. Hasegawa, M. Wada, M. Kataoka, S. Shimizu, Appl. Microbiol. Biotechnol. 2001, 55, 590-595;
17. c) H. Gröger, W. Hummel, S. Buchholz, K. Drauz, T. V. Nguyen, C. Rollmann, H. Hüsken, K. Abokitse, Org. Lett. 2003, 5, 173-176.
18. L. E. S. Brink, J. Tramper, Biotechnol. Bioeng. 1985, 27, 1258-1269.
19. Logarithm of the partition coefficient of a given compound in the standard n-octanol/water two-phase system.
20. C. Laane, S. Boeren, K. Vos, Trends Biotechnol. 1985, 3, 251-252.
21. S. Kise, M. Hayashida, J. Biotechnol. 1990, 14, 221-228.
22. Either high amounts of enzyme were needed, for example: J. R. Matos, C.-H. Wong, J. Org. Chem. 1986, 51, 2388-2389; or fast deactivation was detected for example: M. Wolberg, Dissertation, Universität Oldenburg, 2001.
23. Either high amounts of enzyme were needed, for example: J. R. Matos, C.-H. Wong, J. Org. Chem. 1986, 51, 2388-2389; or fast deactivation was detected for example: M. Wolberg, Dissertation, Universität Oldenburg, 2001.
24. a) J. Peters in Biotechnology, Vol. 8a, 2nd ed. (Eds.: H.-J. Rehm, G. Reed), Wiley-VCH, Weinheim, 1998, pp. 391-474;
25. b) S.-I. Suye, K. Kamiya, T. Kawamoto, A. Tanaka, Biocatal. Biotransform. 2002, 20, 23-28;
26. c) W. Kruse, W. Hummel, U. Kragl, Recl. Trav. Chim. Pays-Bas 1996, 115, 239-243.
27. M. H. Vermuë, J. Tramper, Pure Appl. Chem. 1995, 67, 345-373.
28. V. Y. Mozhaev, Y. L. Khmelnitsky, M. V. Sergeeva, A. B. Belova, N. L. Klyachko, A. V. Levashov, K. Martinek, Eur. J. Biochem. 1989, 184, 597-602.
29. HLADH requires NADH as cofactor, TBADH and LBADH require NADPH as cofactor. The LBADH used in this work was overexpressed in a recombinant Escherichia coli strain and used in the form of crude cell extract, see: B. Riebel, Dissertation, Universität Düsseldorf, 1996.
30. A. K. Ghose, G. M. Crippen, J. Chem. Inf. Comput. Sci. 1987, 27, 21-35.
31. To minimize changes in the phase volumes, the organic solvent was previously saturated with water. The reaction mixture was shaken vigorously for one minute resulting in the saturation of the aqueous phase with the organic solvent.
32. Protocol for the standard assays are available as Supporting Information.
33. Neither the nature (competitive, uncompetitive or noncompetitive) nor the cause of this instantaneous inhibition was further investigated; the values are available as supporting information.
34. dea.
35. After the equilibrium conversion had been reached, the organic phase containing the product was removed and replaced by a fresh solution of acetophenone in MTBE, so that conversion could take place anew.
36. See: a) P. A. Fitzpatrick, A. M. Klibanov, J. Am. Chem. Soc. 1991, 113, 3166-3171;
37. b) A. Jönsson, E. Wehtje, P. Adlercreutz, B. Mattiasson, Biochim. Biophys. Acta 1999, 1430, 313-322.
38. a) W. Hummel, M.-R. Kula, Eur. J. Biochem. 1989, 184, 1-13;
39. b) T. Schubert, W. Hummel, M. Müller, Angew. Chem. 2002, 114, 656-659; Angew. Chem. Int. Ed. 2002, 41, 634-637.
40. b) T. Schubert, W. Hummel, M. Müller, Angew. Chem. 2002, 114, 656-659; Angew. Chem. Int. Ed. 2002, 41, 634-637.
41. T. Stillger, M. Bönitz, M. Villela Filho, A. Liese, Chem. Ing. Tech. 2002, 74, 1035-1039.
42. a) M. Wolberg, W. Hummel, C. Wandrey, M. Müller, Angew. Chem. 2000, 112, 4476-4478; Angew. Chem. Int. Ed. 2000, 39, 4306-4308;
43. a) M. Wolberg, W. Hummel, C. Wandrey, M. Müller, Angew. Chem. 2000, 112, 4476-4478; Angew. Chem. Int. Ed. 2000, 39, 4306-4308;
44. b) M. Wolberg, W. Hummel, M. Müller, Chem. Eur. J. 2001, 7, 4562-4571.
45. J. K. Thottahil, Y. Pendri, W. S. Li, D. R. Kronenthal, (Squibb & Sons, Inc.), US 5278313, 1994 [Chem. Abstr. 1994, 120, 217699r].
46. J. K. Thottahil, Y. Pendri, W. S. Li, D. R. Kronenthal, (Squibb & Sons, Inc.), US 5278313, 1994 [Chem. Abstr. 1994, 120, 217699r].
47. To improve the stability of the cofactor it was necessary to increase the aqueous pH-value to 7.0 (5.5 in reference [24]), consequently enhancing the rate of the side reaction. Under this condition the total turnover number of the cofactor (defined as the amount of product per amount of cofactor) was 2500.
48. Cf. A. Ghatorae, G. Bell, P. Halling, Biotechnol. Bioeng. 1994, 13, 331-336.
49. Chemical functionality is a pragmatic label for a set of molecular properties, such as the presence of certain heteroatoms and residues, the absence of others, molecular geometry, electronic density distribution and frontier orbitals, and consequent macroscopic properties of solvents, such as surface tension, solubility, solvatation energy.
50. See Supporting Information.
51. M. Bauer, H. Griengl, W. Steiner, Enzyme Microb. Technol. 1999, 24, 514-522.